Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Total Liabilities (2020 - 2025)

NeuroPace (NPCE) has 6 years of Total Liabilities data on record, last reported at $86.5 million in Q4 2025.

  • For Q4 2025, Total Liabilities changed 0.12% year-over-year to $86.5 million; the TTM value through Dec 2025 reached $86.5 million, changed 0.12%, while the annual FY2025 figure was $86.5 million, 0.12% changed from the prior year.
  • Total Liabilities reached $86.5 million in Q4 2025 per NPCE's latest filing, down from $88.7 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $88.7 million in Q3 2025 and bottomed at $58.3 million in Q2 2021.
  • Average Total Liabilities over 5 years is $77.6 million, with a median of $82.0 million recorded in 2023.
  • Peak YoY movement for Total Liabilities: crashed 70.53% in 2021, then surged 32.09% in 2022.
  • A 5-year view of Total Liabilities shows it stood at $60.1 million in 2021, then skyrocketed by 32.09% to $79.3 million in 2022, then grew by 9.67% to $87.0 million in 2023, then dropped by 0.42% to $86.6 million in 2024, then dropped by 0.12% to $86.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $86.5 million in Q4 2025, $88.7 million in Q3 2025, and $86.7 million in Q2 2025.